DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the systemic bioavailability of DHEA and its
metabolites and the pharmacokinetics of vaginal suppositories at four different DHEA
concentration.
Phase:
Phase 1
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Québec, CHU de Québec CHU de Quebec-Universite Laval